سعر فاركولين محلول تنفسي نقط استنشاق 0.5% 2024

Salbutamol 0.5% respirator solution for nebulisation, 20 mL bottle.

• Relief of bronchospasm in reversible obstructive airway disease and acute attacks of bronchospasm.Population: Patients 12 years and olderDailyMed (U.S. National Library of Medicine)

• In clinical trials (N=135): tremor 20%, dizziness 7%, bronchospasm 8%, nervousness 4%, nausea 4%, cough 4%, bronchitis 4%, headache 3%; tachycardia and hypertension 1%.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to albuterol or any of its components.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Deterioration of asthma: needing more doses than usual may indicate destabilisation and requires re-evaluation; consider anti-inflammatory treatment (e.g. corticosteroids). Paradoxical bronchospasm may occur and may be life threatening.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Other short-acting sympathomimetic aerosol bronchodilators or epinephrineShould not be used concomitantly with albuterol inhalation solution.DailyMed (U.S. National Library of Medicine)

• Not known whether excreted in human milk; because of tumorigenicity in some animal studies, decide whether to discontinue nursing or the drug.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Salbutamol (as sulfate): Stimulates beta-2 adrenergic receptors in airway smooth muscle, increasing cyclic AMP and causing bronchodilation.